Monopar Therapeutics Inc
NASDAQ:MNPR

Watchlist Manager
Monopar Therapeutics Inc Logo
Monopar Therapeutics Inc
NASDAQ:MNPR
Watchlist
Price: 25.82 USD 8.53% Market Closed
Market Cap: 136.3m USD
Have any thoughts about
Monopar Therapeutics Inc?
Write Note

Intrinsic Value

MNPR's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one MNPR stock under the Base Case scenario is 18.23 USD. Compared to the current market price of 25.82 USD, Monopar Therapeutics Inc is Overvalued by 29%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MNPR Intrinsic Value
18.23 USD
Overvaluation 29%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Monopar Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MNPR
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MNPR cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about MNPR?
Bearish
Neutral
Bullish

Fundamental Analysis

25.82 USD
+8.53%
+8.53%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Monopar Therapeutics Inc
US
Biotechnology
Market Cap
136.3m USD
IPO
Dec 19, 2019
Employees
9
United States of America
Market Cap
136.3m USD
Industry
Biotechnology
IPO
Dec 19, 2019
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Monopar Therapeutics Inc

Provide an overview of the primary business activities
of Monopar Therapeutics Inc.

What unique competitive advantages
does Monopar Therapeutics Inc hold over its rivals?

What risks and challenges
does Monopar Therapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Monopar Therapeutics Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Monopar Therapeutics Inc.

Provide P/S
for Monopar Therapeutics Inc.

Provide P/E
for Monopar Therapeutics Inc.

Provide P/OCF
for Monopar Therapeutics Inc.

Provide P/FCFE
for Monopar Therapeutics Inc.

Provide P/B
for Monopar Therapeutics Inc.

Provide EV/S
for Monopar Therapeutics Inc.

Provide EV/GP
for Monopar Therapeutics Inc.

Provide EV/EBITDA
for Monopar Therapeutics Inc.

Provide EV/EBIT
for Monopar Therapeutics Inc.

Provide EV/OCF
for Monopar Therapeutics Inc.

Provide EV/FCFF
for Monopar Therapeutics Inc.

Provide EV/IC
for Monopar Therapeutics Inc.

Show me price targets
for Monopar Therapeutics Inc made by professional analysts.

What are the Revenue projections
for Monopar Therapeutics Inc?

How accurate were the past Revenue estimates
for Monopar Therapeutics Inc?

What are the Net Income projections
for Monopar Therapeutics Inc?

How accurate were the past Net Income estimates
for Monopar Therapeutics Inc?

What are the EPS projections
for Monopar Therapeutics Inc?

How accurate were the past EPS estimates
for Monopar Therapeutics Inc?

What are the EBIT projections
for Monopar Therapeutics Inc?

How accurate were the past EBIT estimates
for Monopar Therapeutics Inc?

Compare the revenue forecasts
for Monopar Therapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Monopar Therapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Monopar Therapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Monopar Therapeutics Inc compared to its peers.

Compare the P/E ratios
of Monopar Therapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Monopar Therapeutics Inc with its peers.

Analyze the financial leverage
of Monopar Therapeutics Inc compared to its main competitors.

Show all profitability ratios
for Monopar Therapeutics Inc.

Provide ROE
for Monopar Therapeutics Inc.

Provide ROA
for Monopar Therapeutics Inc.

Provide ROIC
for Monopar Therapeutics Inc.

Provide ROCE
for Monopar Therapeutics Inc.

Provide Gross Margin
for Monopar Therapeutics Inc.

Provide Operating Margin
for Monopar Therapeutics Inc.

Provide Net Margin
for Monopar Therapeutics Inc.

Provide FCF Margin
for Monopar Therapeutics Inc.

Show all solvency ratios
for Monopar Therapeutics Inc.

Provide D/E Ratio
for Monopar Therapeutics Inc.

Provide D/A Ratio
for Monopar Therapeutics Inc.

Provide Interest Coverage Ratio
for Monopar Therapeutics Inc.

Provide Altman Z-Score Ratio
for Monopar Therapeutics Inc.

Provide Quick Ratio
for Monopar Therapeutics Inc.

Provide Current Ratio
for Monopar Therapeutics Inc.

Provide Cash Ratio
for Monopar Therapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Monopar Therapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Monopar Therapeutics Inc?

What is the current Free Cash Flow
of Monopar Therapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Monopar Therapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Monopar Therapeutics Inc

Current Assets 6.1m
Cash & Short-Term Investments 6m
Other Current Assets 49.6k
Current Liabilities 1.1m
Accounts Payable 1.1m
Efficiency

Earnings Waterfall
Monopar Therapeutics Inc

Revenue
0 USD
Operating Expenses
-7m USD
Operating Income
-7m USD
Other Expenses
524.3k USD
Net Income
-6.5m USD

Free Cash Flow Analysis
Monopar Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MNPR Profitability Score
Profitability Due Diligence

Monopar Therapeutics Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional ROIC
Negative Free Cash Flow
Negative Operating Income
43/100
Profitability
Score

Monopar Therapeutics Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

MNPR Solvency Score
Solvency Due Diligence

Monopar Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Monopar Therapeutics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MNPR Price Targets Summary
Monopar Therapeutics Inc

Wall Street analysts forecast MNPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MNPR is 27.88 USD with a low forecast of 22.22 USD and a high forecast of 38.85 USD.

Lowest
Price Target
22.22 USD
14% Downside
Average
Price Target
27.88 USD
8% Upside
Highest
Price Target
38.85 USD
50% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MNPR?

Click here to dive deeper.

Dividends

Monopar Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MNPR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MNPR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one MNPR stock?

The intrinsic value of one MNPR stock under the Base Case scenario is 18.23 USD.

Is MNPR stock undervalued or overvalued?

Compared to the current market price of 25.82 USD, Monopar Therapeutics Inc is Overvalued by 29%.

Back to Top